John Cush/rheumnow.com
Jan 11, 2026, 06:59
John Cush: Subcutaneous Anifrolumab Effective in Lupus
John Cush, Executive Editor at RheumNow.com, shared a post on LinkedIn:
“Subcutaneous Anifrolumab Effective in Lupus
A new study published in Arthritis and Rheumatology demonstrates that subcutaneous administration of anifrolumab provides efficacy comparable to intravenous administration, offering a promising alternative for at-home care of patients living with moderate-to-severe SLE.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 9, 2026, 13:525 Evidence-Based Reasons Not to “Just Keep Trying” – Fertility Plus
-
Aug 9, 2026, 13:34The Future of Embryology Depends on How We Train the Next Generation – ASRM
-
Aug 9, 2026, 13:22Ritik Shukla: Menopause Is Not the End of Vitality – It’s the Beginning of a New Chapter
-
Aug 9, 2026, 12:57Szabó Gábor: 2 Imaging Modalities for Detecting Endometriosis
-
Aug 9, 2026, 12:36Shehab Gamal: Your Fertility Might Be Sitting in Your Fridge
-
Aug 9, 2026, 12:14Why Language Shapes PMOS Care – PCOS Awareness Association
-
Aug 9, 2026, 11:46Veekesh Roy: A Simple Overview of the Science Behind IVF and Modern Reproductive Medicine
-
Aug 9, 2026, 11:38Diet and Fertility in Women: Expert Insights with Bunafsha Subhani – Valley Fertility Centre
-
Aug 8, 2026, 20:02Lowell Ku: Excited to Speak at the ASRM 2026 Scientific Congress and Expo